1. Jha S, Shah S, Calderon MD, Soin A, Manchikanti L. The effect of COVID-19 on interventional pain management practices: a physician burnout survey. Pain Physician. 2020;23(4S):S271–82 (PMID: 32942787).
2. Manchikanti L, Pampati V, Jha SS, et al. The impact of COVID-19 on interventional pain management practices is significant and long-lasting: an interventional pain management physician survey. Pain Physician. 2022;25(2):131–44 (PMID: 35322967).
3. Manchikanti L, Pampati V, Sanapati MR, et al. COVID-19 pandemic reduced utilization of interventional techniques 18.7% in Managing chronic pain in the Medicare population in 2020: Analysis of utilization data from 2000 to 2020. Pain Physician. 2022;25(3):223–38 (PMID: 35652763).
4. Manchikanti L, Singh VM, Staats PS, et al. Fourth wave of opioid (illicit drug) overdose deaths and diminishing access to prescription opioids and interventional techniques: cause and effect. Pain Physician. 2022;25(2):97–124 (PMID: 35322965).
5. Manchikanti L, Vanaparthy R, Atluri S, Sachdeva H, Kaye AD, Hirsch JA. COVID-19 and the opioid epidemic: two public health emergencies that intersect with chronic pain. Pain Ther. 2021;10(1):269–86. https://doi.org/10.1007/s40122-021-00243-2. (Epub 2021 Mar 14. PMID: 33718982; PMCID: PMC7955940).